Kristopher Jonas: Why Donors Show Up and Why It All Matters
Kristopher Jonas, Chief Executive Officer/President at Proesis Biologics, shared a post on LinkedIn:
”This recent piece from Peter Jaworski that sparked a different reflection for me.
In plasma, we spend a lot of time talking about why people donate.
But the truth is, people show up for different reasons. And, they’re all valid.
- Some are motivated by helping patients
- Some are motivated by the compensation
- Some are in between
Here’s the part that matters:
Our responsibility isn’t to judge the reason. It’s to respect the decision.
Because regardless of why someone walks through the door…they are contributing to a system that patients depend on.
And that deserves to be met with:
- Respect
- Dignity
- Appreciation
Every single time.
If we want to build a sustainable plasma supply, this principle has to be foundational:
- Fierce donor advocacy means showing up for the donor, without conditions.
- Not when it’s convenient.
- Not when it fits a narrative.
- Every time.
That’s how trust is built.
And in this industry, trust is everything.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines